Ascendis Pharma AS (ASND) — Cash Flow Quality Index

Latest as of March 2026: -0.01x

Ascendis Pharma AS (ASND) has a Cash Flow Quality Index of -0.01x as of March 2026. Operating cash flow of $-7.85 Million is below net income of $639.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Ascendis Pharma AS debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.01x
Operating CF / Net Income

Operating Cash Flow

$-7.85 Million
USD

Net Income

$639.69 Million
USD

Data as of

Mar 2026
Most recent filing

Ascendis Pharma AS Cash Flow Quality Index (2012–2013)

Historical Cash Flow Quality Index for Ascendis Pharma AS across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Ascendis Pharma AS generate cash.

Annual Cash Flow Quality Index for Ascendis Pharma AS (2012–2013)

Year-by-year earnings quality comparison for Ascendis Pharma AS.

Year Quality Index Operating CF (USD) Net Income YoY Change
2013 1.55x $6.31 Million $4.08 Million ▲ +396.6%
2012 -0.52x $-652.00K $1.25 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.